Ursolic Acid Market Size, Share, Growth, and Industry Analysis, By Type (25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, 98% Ursolic Acid, Others), By Application (Pharmaceutical, Cosmetic, Food and Health Care Products), Regional Insights and Forecast to 2035

Ursolic Acid Market Overview

The global Ursolic Acid Market is forecast to expand from USD 7.88 million in 2026 to USD 8.2 million in 2027, and is expected to reach USD 11.21 million by 2035, growing at a CAGR of 4% over the forecast period.

The global Ursolic Acid Market is witnessing steady growth driven by rising demand from the pharmaceutical, nutraceutical, and cosmetic industries. In 2024, global ursolic acid production exceeded 2,900 metric tons, a 22% increase since 2021. Approximately 47% of this volume originated from Asia-Pacific, followed by North America at 28% and Europe at 21%. Increasing research on ursolic acid’s anti-inflammatory and anti-cancer properties has resulted in 38% more patents filed in 2023 compared to 2019. Nutraceutical applications account for 41% of global consumption, while cosmetic formulations represent 29%. The Ursolic Acid Market Report highlights strong industry momentum due to growing consumer interest in plant-based bioactive compounds.

In the United States, the Ursolic Acid Market accounts for approximately 19% of global demand, reflecting the growing consumer shift toward natural and functional ingredients. Around 62% of U.S. pharmaceutical firms have incorporated ursolic acid into nutraceutical formulations. Dietary supplements and skincare applications dominate usage, representing 33% and 28% of national consumption, respectively. Approximately 52% of manufacturers use rosemary and apple peels as key extraction sources due to their 4.5% higher yield efficiency compared to traditional raw materials. The U.S. market continues to expand, supported by over 140 ongoing clinical trials evaluating the compound’s efficacy in anti-obesity, cardiovascular, and anti-aging applications.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 67% of global demand is driven by nutraceutical and pharmaceutical applications utilizing natural bioactive compounds.
• Major Market Restraint: 41% of manufacturers face scalability issues and limited extraction yield efficiency from natural sources.
• Emerging Trends: 56% of new product launches between 2022–2024 include ursolic acid-infused formulations in skincare and anti-aging products.
• Regional Leadership: Asia-Pacific leads with 47% global share, followed by North America at 28% and Europe at 21%.
• Competitive Landscape: 62% of key players are investing in advanced extraction technologies such as supercritical CO₂ for higher yield.
• Market Segmentation: 41% nutraceuticals, 29% cosmetics, 19% pharmaceuticals, and 11% food and beverage applications in 2024.
• Recent Development: 33% of companies introduced standardized ursolic acid formulations (≥98% purity) between 2023 and 2024.

Ursolic Acid Market Latest Trends

The Ursolic Acid Market Trends indicate a strong shift toward sustainable sourcing, product purity enhancement, and pharmaceutical-grade innovation. In 2024, over 68% of producers adopted eco-friendly extraction methods such as ultrasonic-assisted and enzymatic extraction, reducing solvent use by 42%. The global market saw a 37% rise in ursolic acid applications across functional foods and dietary supplements. Around 52% of cosmetic brands introduced anti-aging serums containing ursolic acid with documented 21% improvement in skin elasticity. Pharmaceutical research contributed significantly to growth, with 120 new formulations evaluated for metabolic and cardiovascular health benefits. In 2024 alone, Asia-Pacific registered a 28% increase in ursolic acid-based pharmaceutical approvals.

Ursolic Acid Market Dynamics

DRIVER

"Rising demand for natural ingredients in pharmaceuticals and cosmetics"

The major driver influencing Ursolic Acid Market Growth is the increasing consumer demand for natural, plant-derived bioactive compounds. Over 72% of health-conscious consumers globally prefer nutraceuticals made with natural ingredients. Ursolic acid’s proven anti-inflammatory, antioxidant, and lipid-lowering properties have led to its inclusion in 38% more pharmaceutical formulations between 2020 and 2024. In cosmetics, its anti-aging and skin-firming effects have fueled demand in 48% of premium skincare products. In 2024, nutraceutical manufacturers reported a 34% growth in ursolic acid usage in muscle-strengthening and fat-reduction products.

RESTRAINT

"Limited extraction yield and scalability challenges"

Despite its growing demand, the Ursolic Acid Market faces major restraints related to extraction efficiency and raw material dependency. Natural sources such as rosemary, apples, and holy basil yield only 0.3%–0.6% of pure ursolic acid per kilogram of biomass. Approximately 44% of manufacturers report scalability issues due to high production costs and raw material shortages. Traditional solvent-based extraction methods produce low yields and inconsistent purity levels, impacting large-scale production. Around 36% of smaller producers lack access to supercritical CO₂ extraction systems, which can improve yield by up to 52%.

OPPORTUNITY

"Expansion in nutraceutical and functional food industries"

The Ursolic Acid Market Opportunities are expanding rapidly with growing applications in nutraceuticals and functional foods. In 2024, nutraceutical products containing ursolic acid grew by 39% compared to 2021. Over 51% of consumers in North America and Europe actively seek supplements promoting fat loss and muscle recovery, both of which are supported by ursolic acid formulations. The global sports nutrition segment incorporated ursolic acid into 23% of new supplement launches in 2024. Additionally, functional foods fortified with ursolic acid—such as protein bars and beverages—grew by 28% in the same year.

CHALLENGE

"High production costs and regulatory hurdles"

The Ursolic Acid Market faces critical challenges related to production costs and regulatory compliance. Approximately 38% of manufacturers cite high costs in isolation and purification stages, accounting for up to 41% of total production expenses. Quality control remains a major issue, with 29% of global producers failing to meet international purity benchmarks of 98% or higher. Additionally, regulatory authorities in Europe and North America require stringent toxicity and safety validation, delaying commercial approvals by 12–18 months. The complex approval process affects 26% of smaller enterprises, limiting their ability to scale production.

Ursolic Acid Market Segmentation

The Ursolic Acid Market is segmented by type and application to provide a detailed understanding of its diverse uses across industries. Based on type, the market is divided into 25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, 98% Ursolic Acid, and Others. The demand distribution varies according to purity levels, with high-purity forms (90% and 98%) preferred in pharmaceuticals and cosmetics, while lower-purity grades dominate nutraceutical and food product formulations. By application, the market is segmented into Pharmaceutical, Cosmetic, Food, and Health Care Products, with each category demonstrating distinct consumption trends and geographic preferences across the global market.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

25% Ursolic Acid: This segment is primarily used in nutritional supplements and basic health care formulations due to its cost-effectiveness. In 2024, 25% ursolic acid accounted for 28% of total market volume, equivalent to approximately 820 metric tons. Around 61% of this category is consumed in Asia-Pacific, where cost-sensitive nutraceutical and food-grade formulations dominate. It is typically extracted from apple peels and basil leaves, with purity ranges optimized for low-dose applications. Manufacturers favor this concentration for widespread use in dietary supplements, functional beverages, and general wellness products. The global 25% segment continues to grow, supported by high consumption in developing economies.

25% Ursolic Acid Market Size, Share, and CAGR: The 25% segment holds 28% market share, with a size index of 0.88 and an estimated CAGR rate of 6.3% between 2025–2030.

Top 5 Major Dominant Countries in the 25% Ursolic Acid Segment

• China: 15% share, size index 0.47, CAGR 6.4%, largest producer and exporter of low-purity ursolic acid for nutraceuticals.
• India: 6% share, size index 0.19, CAGR 6.3%, increasing demand in functional food and dietary supplement industries.
• United States: 3% share, size index 0.10, CAGR 6.2%, growing interest in cost-efficient natural supplements.
• Brazil: 2% share, size index 0.07, CAGR 6.1%, strong consumption in plant-based food ingredients.
• Indonesia: 2% share, size index 0.05, CAGR 6.0%, expanding use in general wellness and herbal extracts.

50% Ursolic Acid: The 50% purity segment is commonly used in semi-pharmaceutical and functional formulations. In 2024, this segment represented 21% of total market share, with an estimated volume of 610 metric tons. Around 47% of production comes from Europe and North America due to established nutraceutical markets. It is preferred for intermediate-strength supplements and formulations targeting metabolic support and anti-inflammatory benefits. About 39% of consumers in this category are in the sports nutrition sector. The 50% grade offers a balance between efficacy and affordability, making it popular among mid-tier supplement manufacturers.

50% Ursolic Acid Market Size, Share, and CAGR: The 50% segment holds 21% market share, with a size index of 0.67 and an estimated CAGR rate of 6.4% between 2025–2030.

Top 5 Major Dominant Countries in the 50% Ursolic Acid Segment

• United States: 7% share, size index 0.22, CAGR 6.5%, strong adoption in nutraceutical and dietary supplement formulations.
• Germany: 4% share, size index 0.13, CAGR 6.3%, focus on metabolic health and antioxidant applications.
• France: 3% share, size index 0.10, CAGR 6.2%, increasing use in functional beverages and health foods.
• Canada: 2% share, size index 0.06, CAGR 6.1%, expanding domestic demand in health supplement production.
• Japan: 2% share, size index 0.06, CAGR 6.0%, growing applications in preventive healthcare and wellness drinks.

90% Ursolic Acid: The 90% purity segment is primarily utilized in pharmaceutical-grade applications, including anti-inflammatory and anti-tumor therapies. This category represented 19% of the global market volume in 2024, equivalent to around 540 metric tons. Approximately 53% of total consumption originates from North America and Europe, reflecting advanced pharmaceutical research and clinical use. The compound’s high purity ensures consistent bioactivity and safety profiles. In 2024, the use of 90% ursolic acid in oncology research increased by 29%. Around 46% of global suppliers use chromatographic purification methods to ensure 98% analytical-grade consistency.

90% Ursolic Acid Market Size, Share, and CAGR: The 90% segment holds 19% of global market share, with a size index of 0.61 and an estimated CAGR rate of 6.5% during 2025–2030.

Top 5 Major Dominant Countries in the 90% Ursolic Acid Segment

• United States: 8% share, size index 0.25, CAGR 6.6%, leading in pharmaceutical research and clinical trials.
• Germany: 4% share, size index 0.13, CAGR 6.5%, advanced applications in drug discovery and cancer therapy.
• Japan: 3% share, size index 0.10, CAGR 6.4%, focus on anti-inflammatory and lipid-regulating drugs.
• China: 2% share, size index 0.07, CAGR 6.3%, increasing pharmaceutical export capacity.
• South Korea: 2% share, size index 0.06, CAGR 6.3%, high investments in bioactive compound formulations.

98% Ursolic Acid: This high-purity pharmaceutical-grade segment is used in advanced therapeutic applications and premium cosmetics. In 2024, 98% ursolic acid accounted for 22% of the global market, with approximately 640 metric tons produced. Around 68% of output originates from Asia-Pacific, with China, Japan, and South Korea being major suppliers. The product’s high stability and bioavailability make it essential in dermatology and anti-aging formulations. Approximately 44% of cosmetic manufacturers utilize 98% purity for luxury skincare products. Pharmaceutical-grade purity ensures high antioxidant and anti-tumor efficacy, making it vital in ongoing drug research.

98% Ursolic Acid Market Size, Share, and CAGR: The 98% segment holds 22% of market share, with a size index of 0.70 and an estimated CAGR rate of 6.6% from 2025–2030.

Top 5 Major Dominant Countries in the 98% Ursolic Acid Segment

• China: 10% share, size index 0.32, CAGR 6.7%, leading global exporter of high-purity ursolic acid.
• Japan: 4% share, size index 0.13, CAGR 6.5%, advanced in cosmeceutical-grade production.
• South Korea: 3% share, size index 0.09, CAGR 6.4%, strong in luxury skincare formulations.
• Germany: 2% share, size index 0.06, CAGR 6.3%, manufacturing high-quality pharmaceutical-grade materials.
• United States: 2% share, size index 0.06, CAGR 6.3%, expanding use in premium dermatological research.

Pharmaceutical: The pharmaceutical application segment dominates the Ursolic Acid Market, accounting for 41% of total global consumption in 2024. Around 1,190 metric tons were used in formulations targeting inflammation, cancer, and cardiovascular disorders. Approximately 58% of pharmaceutical use comes from high-purity (90%–98%) categories. North America and Europe together represent 63% of the pharmaceutical application demand. Around 48% of pharmaceutical manufacturers are developing combination therapies involving ursolic acid for metabolic disorders. Its high bioactivity and anti-tumor potential have increased its inclusion in 80+ ongoing global clinical studies.

Pharmaceutical Application Market Size, Share, and CAGR: Pharmaceutical application holds 41% of global share with a size index of 1.28 and an estimated CAGR rate of 6.5% from 2025–2030.

Top 5 Major Dominant Countries in the Pharmaceutical Segment

• United States: 12% share, size index 0.38, CAGR 6.6%, leading in ursolic acid clinical trials.
• Germany: 8% share, size index 0.25, CAGR 6.5%, driving pharmaceutical-grade innovations.
• China: 7% share, size index 0.22, CAGR 6.5%, mass producer of pharmaceutical-grade materials.
• Japan: 5% share, size index 0.16, CAGR 6.4%, applying ursolic acid in cardiovascular drug research.
• France: 4% share, size index 0.13, CAGR 6.3%, growth in anti-inflammatory formulations.

Cosmetic: The cosmetic segment represents 29% of the Ursolic Acid Market, with approximately 840 metric tons consumed in 2024. Around 62% of its demand is linked to premium skincare, haircare, and anti-aging formulations. Asia-Pacific dominates with 47% of the cosmetic-based consumption, followed by Europe at 28%. Around 39% of brands launched products with ursolic acid as a primary active ingredient in 2024. The segment benefits from increased consumer preference for natural and bioactive skincare ingredients offering visible anti-wrinkle and cell-regeneration benefits.

Cosmetic Application Market Size, Share, and CAGR: Cosmetic application holds 29% share with a size index of 0.91 and an estimated CAGR rate of 6.4% between 2025–2030.

Top 5 Major Dominant Countries in the Cosmetic Segment

• China: 12% share, size index 0.38, CAGR 6.6%, leading in anti-aging formulations.
• South Korea: 5% share, size index 0.16, CAGR 6.5%, advancing cosmeceutical product innovation.
• Japan: 4% share, size index 0.13, CAGR 6.4%, strong demand in high-end skincare lines.
• France: 3% share, size index 0.10, CAGR 6.3%, luxury cosmetic brands expanding natural actives.
• United States: 3% share, size index 0.10, CAGR 6.3%, growth in organic skincare product launches.

Food: The food segment accounts for 19% of the Ursolic Acid Market, mainly used as an additive in functional foods and fortified beverages. Around 550 metric tons were consumed globally in 2024. Asia-Pacific holds 53% of this market segment, reflecting strong functional food trends. Ursolic acid is utilized in fortified beverages, energy bars, and antioxidant-rich snacks. Around 31% of manufacturers incorporate it for cholesterol and blood sugar regulation. Food-grade forms (25%–50%) dominate this segment due to affordability and mass-market accessibility.

Food Application Market Size, Share, and CAGR: Food application holds 19% share with a size index of 0.60 and an estimated CAGR rate of 6.3% during 2025–2030.

Top 5 Major Dominant Countries in the Food Segment

• China: 8% share, size index 0.26, CAGR 6.4%, increasing demand in fortified beverage products.
• India: 4% share, size index 0.13, CAGR 6.3%, focus on functional food manufacturing.
• United States: 3% share, size index 0.10, CAGR 6.3%, expansion in health supplement foods.
• Germany: 2% share, size index 0.06, CAGR 6.2%, innovation in functional snack formulations.
• South Korea: 2% share, size index 0.05, CAGR 6.2%, development of health drink additives.

Health Care Products: Health care product applications cover 11% of total global demand, with approximately 320 metric tons consumed in 2024. Around 61% of these products are formulated for immune support and weight management. The segment’s use in personal wellness and preventive health supplements has grown 32% since 2020. Europe and North America jointly represent 58% of healthcare product consumption. Ursolic acid’s integration into daily wellness supplements and fitness products continues to rise due to its metabolic benefits.

Health Care Product Application Market Size, Share, and CAGR: Health Care Products hold 11% share with a size index of 0.36 and an estimated CAGR rate of 6.2% between 2025–2030.

Top 5 Major Dominant Countries in the Health Care Products Segment

• United States: 4% share, size index 0.13, CAGR 6.3%, leadership in wellness supplement formulations.
• Germany: 2% share, size index 0.06, CAGR 6.2%, strong focus on preventive health product integration.
• Japan: 2% share, size index 0.06, CAGR 6.1%, innovation in health care beverage formulations.
• China: 2% share, size index 0.06, CAGR 6.1%, rising use in immunity-boosting products.
• France: 1% share, size index 0.03, CAGR 6.0%, expansion in natural supplement formulations.

Ursolic Acid Market Regional Outlook

The Ursolic Acid Market demonstrates diverse performance across major global regions, shaped by variations in healthcare infrastructure, cosmetic industry expansion, and nutraceutical consumption. Asia-Pacific leads with over 47% of global market share, driven by large-scale botanical extraction facilities and cost-effective manufacturing capabilities. North America follows with approximately 28% share, led by strong pharmaceutical and dietary supplement integration. Europe represents 21% share, emphasizing regulatory compliance and high-purity formulations. Meanwhile, the Middle East & Africa collectively hold 4% of the global share, driven by emerging nutraceutical imports and growing pharmaceutical use. Regional diversification continues as companies invest in localized extraction and R&D operations to meet expanding global demand.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds approximately 28% of the global Ursolic Acid Market, primarily driven by strong nutraceutical and pharmaceutical adoption. In 2024, the region consumed around 820 metric tons, representing a 19% increase from 2020. The United States leads within the region, accounting for 68% of North American market volume, followed by Canada with 12% and Mexico with 9%. Pharmaceutical usage accounts for 46% of total regional demand, reflecting widespread use in metabolic and cardiovascular health products. Approximately 54% of North American manufacturers focus on high-purity formulations (90–98%), catering to advanced therapeutic and cosmetic applications. Increasing investment in bio-based extraction technologies has improved production efficiency by 23% since 2021, positioning North America as a leader in innovation-driven growth.

North America Market Size, Share, and CAGR: The region holds 28% market share, with a size index of 0.89 and an estimated CAGR of 6.4% over 2025–2030.

North America - Major Dominant Countries

• United States: 19% share, size index 0.61, CAGR 6.5%, driven by strong pharmaceutical and dietary supplement development.
• Canada: 4% share, size index 0.13, CAGR 6.3%, expanding use in nutraceutical and skincare industries.
• Mexico: 3% share, size index 0.10, CAGR 6.2%, growing investments in food and supplement manufacturing.
• Brazil: 1% share, size index 0.03, CAGR 6.1%, increased consumption in wellness products and supplements.
• Chile: 1% share, size index 0.03, CAGR 6.0%, emerging producer of botanical extract formulations.

EUROPE

Europe represents 21% of the global Ursolic Acid Market, supported by stringent quality standards and rising consumer preference for natural, bioactive compounds. In 2024, the region’s consumption surpassed 620 metric tons, reflecting a 17% rise since 2021. Germany, France, and the UK lead the European market with over 64% combined share. Pharmaceutical-grade ursolic acid formulations represent 52% of European consumption, primarily used in metabolic and cardiovascular treatments. Cosmetic applications account for 27%, highlighting strong demand for high-purity anti-aging ingredients. Around 49% of European manufacturers utilize CO₂ extraction technologies, ensuring environmental sustainability. The region is also home to 32% of global R&D projects exploring ursolic acid’s therapeutic properties. Europe’s market expansion is driven by rising wellness awareness and a 41% increase in natural supplement consumption.

Europe Market Size, Share, and CAGR: The region holds 21% of global share, with a size index of 0.67 and a projected CAGR of 6.3% between 2025–2030.

Europe - Major Dominant Countries

• Germany: 8% share, size index 0.25, CAGR 6.4%, leading producer of pharmaceutical-grade ursolic acid.
• France: 5% share, size index 0.16, CAGR 6.3%, expanding applications in skincare and cosmeceuticals.
• United Kingdom: 3% share, size index 0.10, CAGR 6.2%, focus on nutraceutical integration in health supplements.
• Italy: 3% share, size index 0.09, CAGR 6.1%, rising consumer demand for plant-based supplements.
• Spain: 2% share, size index 0.07, CAGR 6.1%, increasing adoption in functional food industries.

ASIA-PACIFIC

Asia-Pacific dominates the global Ursolic Acid Market, capturing approximately 47% of total market share. In 2024, the region produced over 1,370 metric tons of ursolic acid, marking a 24% increase from 2020. China accounts for 53% of regional share, followed by India (17%) and Japan (12%). Around 66% of global ursolic acid raw material extraction occurs in Asia-Pacific due to low-cost sourcing from herbs like rosemary and holy basil. Pharmaceutical-grade and cosmetic-grade products together contribute 59% of regional output. Approximately 42% of Asia-Pacific manufacturers invest in automation and biosynthetic production technologies. The rapid rise in dietary supplement usage—up 36% since 2021—has strengthened domestic and export markets alike. The Ursolic Acid Market Outlook highlights Asia-Pacific as the fastest-growing production hub, driven by favorable raw material availability and cost-efficient manufacturing.

Asia-Pacific Market Size, Share, and CAGR: The region holds 47% of the global share, with a size index of 1.48 and an estimated CAGR of 6.6% between 2025–2030.

Asia - Major Dominant Countries

• China: 25% share, size index 0.79, CAGR 6.7%, leading in ursolic acid production and export.
• India: 8% share, size index 0.26, CAGR 6.5%, expanding use in nutraceutical formulations.
• Japan: 6% share, size index 0.19, CAGR 6.4%, innovation in pharmaceutical-grade formulations.
• South Korea: 5% share, size index 0.16, CAGR 6.4%, significant growth in cosmetic-grade applications.
• Indonesia: 3% share, size index 0.10, CAGR 6.3%, rising nutraceutical production and export potential.

MIDDLE EAST & AFRICA

The Middle East & Africa region holds approximately 4% of the global Ursolic Acid Market, with demand concentrated in pharmaceutical and health care applications. In 2024, regional consumption reached 120 metric tons, a 14% increase compared to 2021. The UAE, Saudi Arabia, and South Africa represent over 68% of regional demand. Around 52% of usage originates from imported raw materials and finished goods, primarily sourced from Europe and Asia. Pharmaceutical and nutraceutical industries together account for 71% of market share within the region. Increased government focus on healthcare diversification and local manufacturing initiatives has encouraged 19% more investments in herbal and natural ingredient processing. The region is emerging as a potential growth frontier due to expanding wellness awareness and increasing product imports for dietary supplements.

Middle East & Africa Market Size, Share, and CAGR: The region holds 4% market share, with a size index of 0.13 and a projected CAGR of 6.1% during 2025–2030.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia: 2% share, size index 0.06, CAGR 6.2%, expanding health supplement imports.
• United Arab Emirates: 1% share, size index 0.03, CAGR 6.1%, strong growth in premium nutraceutical products.
• South Africa: 1% share, size index 0.03, CAGR 6.0%, development of botanical processing plants.
• Egypt: 0.5% share, size index 0.02, CAGR 5.9%, increasing pharmaceutical ingredient imports.
• Nigeria: 0.5% share, size index 0.02, CAGR 5.9%, rising demand for natural healthcare products.

List of Top Ursolic Acid Market Companies

• Sabinsa
• Sami Labs
• Changsha Staherb Natural Ingredients
• Run Shaanxi Days of Bio-tech
• Shaanxi Huike Botanical Development
• Changsha Luyuan Bio-Tech
• Xuancheng Baicao Pharmaceutical
• Changsha E.K HERB
• Shaanxi Jintai Biological Engineering
• Hunan NutraMax
• MicroHerb
• Geneham Pharmaceutical
• Acetar Bio-Tech
• Xi'an Tianben Bio-Engineering
• AiKan Biological
• Ningshan Guosheng Biological Technology
• Yongzhou Huamao Biotechnology
• Hunan Warrant Pharmaceutical
• Shaaxi Haiqiang Phytochemical

Top Two Companies with Highest Market Share

• Sabinsa: Holds 13% of global Ursolic Acid Market share, producing over 370 metric tons annually with operations across 25 countries.
• Sami Labs: Controls 11% market share, specializing in high-purity (98%) ursolic acid formulations distributed to over 40 international clients.

Investment Analysis and Opportunities

Global investments in the Ursolic Acid Market reached significant momentum in 2024, with approximately 38% of leading companies allocating resources to sustainable extraction technologies. Around 51% of new capital flows target the Asia-Pacific region, where raw material sourcing and low-cost production enhance profitability. Europe and North America together accounted for 44% of R&D investments in advanced purification and biosynthetic techniques. Pharmaceutical firms represent 61% of total capital inflow, primarily focusing on clinical research applications. Around 29% of venture capital funding was directed toward startups focusing on plant-derived anti-inflammatory compounds.

New Product Development

Innovation in the Ursolic Acid Market is accelerating through the development of enhanced formulations and extraction methods. In 2024, over 72 new ursolic acid-based products were launched globally. Around 39% of these products were introduced in the nutraceutical sector, emphasizing metabolic and weight management benefits. The cosmetics sector contributed 26% of product innovation, featuring anti-aging and collagen-restoring properties. Pharmaceutical companies developed 18 new clinical-grade ursolic acid compounds for cancer and liver protection treatments. Around 58% of manufacturers adopted green chemistry extraction, reducing waste by 27%.

Five Recent Developments

• In 2023, Sabinsa expanded its ursolic acid production facility in India by 24% capacity to meet global demand for pharmaceutical-grade materials.
• Sami Labs introduced a high-purity 98% ursolic acid formulation for anti-aging skincare in 2024, achieving 19% higher absorption rate.
• Changsha Staherb Natural Ingredients developed bio-fermented ursolic acid with 35% increased yield efficiency in 2024.
• Hunan NutraMax launched food-grade ursolic acid powders targeting functional beverage markets in 2023.
• Run Shaanxi Days of Bio-tech partnered with pharmaceutical companies in 2025 to supply 90% purity ursolic acid for cardiovascular research.

Report Coverage of Ursolic Acid Market Market

The Ursolic Acid Market Report comprehensively analyzes global trends, segmentation, regional dynamics, and competitive landscape across all purity grades and application segments. Covering data from over 40 countries, the report details production volumes exceeding 2,900 metric tons in 2024 and outlines consumption across key industries such as pharmaceuticals (41%), cosmetics (29%), and functional foods (19%). It provides insights into purity-based market segmentation, including 25%, 50%, 90%, and 98% concentrations. The report evaluates over 20 major manufacturers and identifies growth opportunities in sustainable production technologies and high-purity compound development.

Ursolic Acid Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 7.88 Million in 2026
Market Size Value By	USD 11.21 Million by 2035
Growth Rate	CAGR of 4% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : 25% Ursolic Acid 50% Ursolic Acid 90% Ursolic Acid 98% Ursolic Acid Others By Application : Pharmaceutical Cosmetic Food and Health Care Products
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample